T2 Biosystems, Inc. Accounts Receivable, after Allowance for Credit Loss
T2 Biosystems, Inc. had Accounts Receivable, after Allowance for Credit Loss of $2.00 million as of 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Balance Sheet › Assets
us-gaap:AccountsReceivableNet · last filed 2024-11-14
- 2024-09-30: Accounts Receivable, after Allowance for Credit Loss $2.00M.
- 2024-06-30: Accounts Receivable, after Allowance for Credit Loss $1.30M.
- 2024-03-31: Accounts Receivable, after Allowance for Credit Loss $1.60M.
- 2023-12-31: Accounts Receivable, after Allowance for Credit Loss $1.40M.
| Period end | Accounts Receivable, after Allowance for Credit Loss |
|---|---|
| 2024-09-30 | $2.00M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.30M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.60M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $1.40M 10-Q · filed 2024-11-14 |
| 2023-09-30 | $1.10M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $1.30M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $1.30M 10-Q · filed 2024-05-06 |
| 2022-12-31 | $2.20M 10-Q · filed 2024-11-14 |
| 2022-09-30 | $1.60M 10-Q · filed 2023-11-15 |
| 2021-12-31 | $5.10M 10-K · filed 2024-04-01 |